{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-169309","form_type":"8-K","ticker":"VRCA","cik":"0001660334","company_name":"Verrica Pharmaceuticals Inc.","filed_at":"2025-07-30T23:59:59+00:00","discovered_at":"2026-05-14T18:02:44.584777+00:00","generated_at":"2026-05-17T23:05:44.640493+00:00","sec_items":["3.01"],"event_type":"regulatory","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Verrica receives Nasdaq delisting notice, implements 1-for-10 reverse split to regain bid price compliance","bullets":["Nasdaq Staff Determination issued July 24, 2025; company may request hearing to stay delisting.","1-for-10 reverse stock split effected July 24, 2025 to increase per-share bid price.","Closing bid price $6.24 on July 29, 2025, above $1.00 minimum for 4 consecutive business days.","Company will request bid price compliance determination after 10 trading days of compliance."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-169309","json":"https://secwatch.observer/filing/0001193125-25-169309.json","markdown":"https://secwatch.observer/filing/0001193125-25-169309.md","text":"https://secwatch.observer/filing/0001193125-25-169309.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1660334/000119312525169309/0001193125-25-169309-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1660334/000119312525169309/d62269d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T23:05:44.640493+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}